From Concept
To Clinical Impact
Our industry partners work closely with SWOG research committees under joint scientific and governance structures to propose, design, and deploy clinical trials. Our partners are jointly involved in all critical decisions about study conduct, analysis, and reporting.
You'll be supported by a dedicated CTP infrastructure for rapid study design and protocol development.
CTP Offers Industry Partners Unique Benefits
Expertise:
-
CTP has demonstrated particular value in:• Rare disease populations• Small or complex studies• Trials difficult for companies to conduct independently• Biomarker-driven studies• Pragmatic clinical trials
Reach:
- CTP partners have access to SWOG’s network of more than 1,300 sites in 47 states, including community hospitals, academic medical centers, and NCI-designated clinical cancer centers.
Efficiency:
- With dedicated CTP infrastructure completely outside the NCI framework, CTP develops and launches trials within industry-standard timelines.
Clinical trials developed with SWOG CTP must not compete with NCI-sponsored trials run by SWOG or other members of the NCI’s National Clinical Trials Network.